Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
Saved in:
| Title: | Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials. |
|---|---|
| Authors: | Burmester, Gerd R.1 (AUTHOR) Gerd.Burmester@charite.de, Stigler, Jayne2 (AUTHOR), Rubbert-Roth, Andrea3 (AUTHOR), Tanaka, Yoshiya4 (AUTHOR), Azevedo, Valderilio F.5 (AUTHOR), Coombs, Derek2 (AUTHOR), Lagunes, Ivan2 (AUTHOR), Lippe, Ralph2 (AUTHOR), Wung, Peter2 (AUTHOR), Gensler, Lianne S.6 (AUTHOR) |
| Source: | Rheumatology & Therapy. Jun2024, Vol. 11 Issue 3, p737-753. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21986576 |
|---|---|
| DOI: | 10.1007/s40744-024-00671-4 |
